While this article puts more faith in the reliability figures from the DSM-5 Field Trials than I have, the account of the history of the endeavor is instructive. My own hypothesis has been that the DSM-5 Task Force leaders didn’t accept the stated DSM-III/DSM-IV atheoretical paradigm themselves [speaking of forests…]. They set out determined to […]
The Op-Ed: A Paradigm Shift In Launching Drugs Pharmalot By Ed Silverman January 8th, 2013 Jamzo points us to this OPED on Pharmalot by: Peter Hansen, who is the senior manager and global product launch lead for the Accenture Life Sciences industry practice, to explain what drugmakers need to know and do if they want […]
he·gem·o·ny [hj-mn] noun 1: preponderant influence or authority over others: domination 2: the social, cultural, ideological, or economic influence exerted by a dominant group Psychiatry is approaching a crisis. For thirty years, it has been dominated by the inertia of the coup d’etat in 1980, the DSM-III revision that became a virtual Declaration of Independence […]
Double Bind theory arose in an attempt the understand family communication patterns that might explain the ontogeny of psychosis, but the pattern of communication has a much wider application. A double bind [or an impossible situation] consists of four elements: the ouvert message: an injunction to perform a certain action the covert message: an equally […]
I couldn’t resist – the cabin with its fresh coat of paint at sunset[that’s Annie peeking over the railing on the steps]
You got to know when to hold them, And know when to fold them. Know when to run away. Know when to hide… Don’t Turn Your Back on Industry, but Keep It Honest Medscape Psychiatry by Jeffrey A. Lieberman, MD Dec 19, 2012 My comments are prompted by an article that was published on November 24 in […]
Just another small point about the Field Trial editorial, this part of the editorial didn’t make any sense to me: The Initial Field Trials of DSM-5: New Blooms and Old Thorns by Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, Susan K. Schultz, Carol A. Tamminga, Glen O. Gabbard, Susan Shur-Fen Gau, Daniel […]
Isn’t it rich, aren’t we a pair Me here at last on the ground – and you in mid-air Send in the clowns Isn’t it bliss, don’t you approve One who keeps tearing around – and one who can’t move But where are the clowns – send in the clowns Just when I stopped opening […]
I was perusing my usual haunts this evening, sort of catching up after a fairly busy holiday season that ate up my leisure time. Pharmagossip had a number of interesting finds. But this one caught my eye because of a particular experience: File under "Perverse Incentives" Pharmagossip by Jack Friday December 31, 2012 You’ve probably […]
Bob Fidaman of Seroxat Sufferers fame passed on an article that he found kind of bizarre [Suicide Prevention and Ketamine – Larkin & Beautrais]. He wasn’t wrong: A preliminary naturalistic study of low-doseketamine for depression and suicide ideation in the emergency department. by Larkin GL and Beautrais AL International Journal of Neuropsychopharmacology. 2011 14[8]:1127-1131. We […]